外源性而非内源性前列腺素调节小鼠骨髓树突状细胞的细胞因子分泌:涉及EP2、DP和IP前列腺素受体,而非EP1、EP3和FP前列腺素受体。
Exogenous but not endogenous prostanoids regulate cytokine secretion from murine bone marrow dendritic cells: EP2, DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved.
作者信息
Józefowski Szczepan, Bobek Małgorzata, Marcinkiewicz Janusz
机构信息
Department of Immunology, Jagiellonian University Medical College, 18 Czysta Street, 31-121, Cracow, Poland.
出版信息
Int Immunopharmacol. 2003 Jun;3(6):865-78. doi: 10.1016/S1567-5769(03)00072-9.
Murine bone marrow-derived dendritic cells (DC), stimulated with lipopolysaccharide (LPS) and/or LPS+interferon-gamma (IFN-gamma), secrete a variety of inflammatory mediators which may modulate their functions. We have examined the potential for exogenous prostanoids, acting in a paracrine fashion, and endogenous prostanoids, acting in an autocrine fashion, to regulate secretion of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), IL-10, and IL-12 in DC. In order to identify receptors mediating these effects, DC were treated in vitro with receptor-selective prostanoids. Agonists of cyclic AMP-elevating receptors, namely, prostaglandin E(2) (PGE(2)), butaprost (EP(2) receptor), iloprost (IP receptor), and BW245C (DP receptor), dose-dependently inhibited the release of IL-6, TNF-alpha, and IL-12 and enhanced the release of IL-10 from LPS-stimulated DC, with TNF-alpha secretion being the most strongly affected. In contrast, 15-deoxy-Delta(12,14)-PGJ(2)-an activator of nuclear peroxisome proliferator-activated receptor-gamma (PPAR-gamma) receptors-inhibited release of all tested cytokines. Exogenous prostanoids, cyclic AMP-elevating analogs, lost their ability to modulate cytokine release in cells pre-incubated for 4 h with LPS, indicating that prostanoids may affect DC functions during initial phases of LPS stimulation only. Sulprostone and (+)-fluprostenol failed to modulate any of responses tested, suggesting lack of involvement/expression of EP(1), EP(3), and FP receptors in DC activation. In order to examine the role of endogenous prostanoids, DC were treated with inhibitors of cyclooxygenases (COX). At concentrations that completely blocked PGE(2) release, neither indomethacin (nonselective inhibitor) nor rofecoxib (COX-2-selective inhibitor) influenced cytokine release from LPS-stimulated DC. Thus, cytokine release from LPS-stimulated DC does not seem to be autoregulated by endogenous prostanoids, whereas in vivo regulatory function may be fulfilled in a paracrine manner by PGD(2), PGE(2), and PGI(2) released from neighboring cells.
用脂多糖(LPS)和/或LPS+干扰素-γ(IFN-γ)刺激的小鼠骨髓来源的树突状细胞(DC)分泌多种炎症介质,这些介质可能调节其功能。我们研究了以旁分泌方式起作用的外源性前列腺素和以自分泌方式起作用的内源性前列腺素调节DC中肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、IL-10和IL-12分泌的潜力。为了鉴定介导这些作用的受体,用受体选择性前列腺素体外处理DC。环磷酸腺苷升高受体的激动剂,即前列腺素E2(PGE2)、布他前列素(EP2受体)、伊洛前列素(IP受体)和BW245C(DP受体),剂量依赖性地抑制LPS刺激的DC中IL-6、TNF-α和IL-12的释放,并增强IL-10的释放,其中TNF-α分泌受影响最强烈。相反,15-脱氧-Δ12,14-前列腺素J2(一种核过氧化物酶体增殖物激活受体-γ(PPAR-γ)受体的激活剂)抑制所有测试细胞因子的释放。外源性前列腺素,即环磷酸腺苷升高类似物,在用LPS预孵育4小时的细胞中失去了调节细胞因子释放的能力,这表明前列腺素可能仅在LPS刺激的初始阶段影响DC功能。舒前列素和(+)-氟前列醇未能调节任何测试的反应,表明DC激活中缺乏EP1、EP3和FP受体参与/表达。为了研究内源性前列腺素的作用,用环氧化酶(COX)抑制剂处理DC。在完全阻断PGE2释放的浓度下,吲哚美辛(非选择性抑制剂)和罗非昔布(COX-2选择性抑制剂)均未影响LPS刺激的DC中细胞因子的释放。因此,LPS刺激的DC中细胞因子的释放似乎不受内源性前列腺素的自动调节,而在体内,邻近细胞释放的PGD2、PGE2和PGI2可能以旁分泌方式发挥调节功能。